FDA Approves Pfizer's COVID-19 Vaccine Emergency Use Despite Fears From Severe Allergic Reactions Reported in UK

The United States Food and Drug Administration (FDA) Key Panel recently expressed their approval on the Emergency Use Authorization of Pfizer and BioNTech's 95 percent effective COVID-19 Vaccine. Deliberations would still come within the FDA, especially with the Pfizer vaccine causing a severe allergic reaction to patients who received the UK's immunization shot.

Over the past week, there has been massive concern regarding Pfizer's COVID-19 vaccine's side effect, which caused severe allergic reaction known as "anaphylaxis" in the United Kingdom. The British country is known to be the first ones to Emergency Approve and use the vaccine for mass immunization shots.

According to the Associated Press, the United Kingdom is now investigating the matter after two patients who received the vaccine suffered "anaphylaxis" or severe allergic reaction because of a foreign substance. The severe allergic reaction may be caused by food, drink, insect bites, vaccines, and other external factors in the environment.

The allergic reaction came as a shock to vaccine administrators, but this is expected because all immunization shots have warnings when sold, particularly with allergy and precautions. Vaccines cannot be administered to everyone as there would always be a risk for people with acute allergic reactions to different substances, not limited to vaccines.

This article is owned by Tech Times

Written by Isaiah Alonzo